Ann Boija

7.4k total citations · 3 hit papers
20 papers, 2.5k citations indexed

About

Ann Boija is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ann Boija has authored 20 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Organic Chemistry. Recurrent topics in Ann Boija's work include Genomics and Chromatin Dynamics (10 papers), RNA Research and Splicing (9 papers) and RNA modifications and cancer (4 papers). Ann Boija is often cited by papers focused on Genomics and Chromatin Dynamics (10 papers), RNA Research and Splicing (9 papers) and RNA modifications and cancer (4 papers). Ann Boija collaborates with scholars based in United States, Sweden and South Korea. Ann Boija's co-authors include Richard A. Young, Isaac A. Klein, Nancy M. Hannett, Alicia V. Zamudio, Benjamin R. Sabari, Krishna Shrinivas, Tong Ihn Lee, Jurian Schuijers, Eliot L. Coffey and Alessandra Dall’Agnese and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Ann Boija

19 papers receiving 2.5k citations

Hit Papers

Transcription Factors Activate Genes through the Phase-Se... 2018 2026 2020 2023 2018 2019 2021 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Boija United States 13 2.3k 183 162 146 104 20 2.5k
John C. Manteiga United States 4 2.0k 0.9× 214 1.2× 157 1.0× 108 0.7× 72 0.7× 6 2.1k
Alessandra Dall’Agnese United States 19 2.5k 1.1× 177 1.0× 197 1.2× 173 1.2× 115 1.1× 27 2.8k
Lena K. Afeyan United States 7 1.8k 0.8× 147 0.8× 146 0.9× 108 0.7× 83 0.8× 9 1.9k
Eliot L. Coffey United States 5 1.7k 0.7× 148 0.8× 150 0.9× 153 1.0× 71 0.7× 5 1.8k
Jenna K. Rimel United States 6 1.7k 0.7× 145 0.8× 94 0.6× 101 0.7× 89 0.9× 9 1.8k
Gina M. Dailey United States 16 2.0k 0.8× 215 1.2× 163 1.0× 131 0.9× 74 0.7× 24 2.2k
Alicia V. Zamudio United States 9 3.1k 1.3× 297 1.6× 285 1.8× 247 1.7× 107 1.0× 9 3.3k
Saskia Hutten Germany 21 2.5k 1.1× 117 0.6× 164 1.0× 137 0.9× 194 1.9× 31 2.9k
Stoyno Stoynov Bulgaria 11 2.3k 1.0× 86 0.5× 90 0.6× 72 0.5× 281 2.7× 28 2.6k
Simon J. Elsässer Sweden 24 2.0k 0.9× 160 0.9× 218 1.3× 101 0.7× 85 0.8× 43 2.3k

Countries citing papers authored by Ann Boija

Since Specialization
Citations

This map shows the geographic impact of Ann Boija's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Boija with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Boija more than expected).

Fields of papers citing papers by Ann Boija

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Boija. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Boija. The network helps show where Ann Boija may publish in the future.

Co-authorship network of co-authors of Ann Boija

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Boija. A scholar is included among the top collaborators of Ann Boija based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Boija. Ann Boija is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akinsanya, Karen, Mohammed AlQuraishi, Ann Boija, et al.. (2025). Redefining druggable targets with artificial intelligence. Nature Biotechnology. 43(9). 1416–1418. 1 indexed citations
2.
Klein, Isaac A., et al.. (2025). Abstract 1751: Beta catenin c-mods are orally bioavailable small-molecules targeting Wnt-driven tumors. Cancer Research. 85(8_Supplement_1). 1751–1751.
3.
Han, Tina W., Bede Portz, Richard A. Young, Ann Boija, & Isaac A. Klein. (2024). RNA and condensates: Disease implications and therapeutic opportunities. Cell chemical biology. 31(9). 1593–1609. 12 indexed citations
4.
West, K. A., et al.. (2024). 155P Targeting colorectal cancer by sequestration of beta-catenin in nuclear condensates. Annals of Oncology. 35. S69–S69. 1 indexed citations
5.
Kilgore, Henry R., Peter G. Mikhael, Kalon J. Overholt, et al.. (2023). Distinct chemical environments in biomolecular condensates. Nature Chemical Biology. 20(3). 291–301. 51 indexed citations
6.
Neumayr, Christoph, Vanja Haberle, Leonid Serebreni, et al.. (2022). Differential cofactor dependencies define distinct types of human enhancers. Nature. 606(7913). 406–413. 55 indexed citations
7.
Boija, Ann, et al.. (2022). p300/CBP sustains Polycomb silencing by non-enzymatic functions. Molecular Cell. 82(19). 3580–3597.e9. 19 indexed citations
8.
Pomplun, Sebastian, Muhammad Jbara, Carly K. Schissel, et al.. (2021). Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription. ACS Central Science. 7(8). 1408–1418. 26 indexed citations
9.
Jbara, Muhammad, Sebastian Pomplun, Carly K. Schissel, et al.. (2021). Engineering Bioactive Dimeric Transcription Factor Analogs via Palladium Rebound Reagents. Journal of the American Chemical Society. 143(30). 11788–11798. 35 indexed citations
10.
Boija, Ann, Isaac A. Klein, & Richard A. Young. (2021). Biomolecular Condensates and Cancer. Cancer Cell. 39(2). 174–192. 213 indexed citations breakdown →
11.
Klein, Isaac A., Ann Boija, Lena K. Afeyan, et al.. (2021). Partitioning of cancer therapeutics in nuclear condensates.. Journal of Clinical Oncology. 39(15_suppl). 3131–3131. 3 indexed citations
12.
Guo, Yang, John C. Manteiga, Jonathan E. Henninger, et al.. (2019). Pol II phosphorylation regulates a switch between transcriptional and splicing condensates. Nature. 572(7770). 543–548. 455 indexed citations breakdown →
13.
Shrinivas, Krishna, Benjamin R. Sabari, Eliot L. Coffey, et al.. (2019). Enhancer Features that Drive Formation of Transcriptional Condensates. Molecular Cell. 75(3). 549–561.e7. 281 indexed citations
14.
Boija, Ann, Isaac A. Klein, Benjamin R. Sabari, et al.. (2018). Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains. Cell. 175(7). 1842–1855.e16. 1200 indexed citations breakdown →
15.
Boija, Ann, Dig Bijay Mahat, Per-Henrik Holmqvist, et al.. (2017). CBP Regulates Recruitment and Release of Promoter-Proximal RNA Polymerase II. Molecular Cell. 68(3). 491–503.e5. 59 indexed citations
16.
Boija, Ann, Edvin Karlsson, Per-Henrik Holmqvist, et al.. (2017). Atrophin controls developmental signaling pathways via interactions with Trithorax-like. eLife. 6. 27 indexed citations
17.
Boija, Ann & Mattias Mannervik. (2016). Initiation of diverse epigenetic states during nuclear programming of the Drosophila body plan. Proceedings of the National Academy of Sciences. 113(31). 8735–8740. 11 indexed citations
18.
Philip, Philge, Ann Boija, Roshan Vaid, et al.. (2015). CBP binding outside of promoters and enhancers in Drosophila melanogaster. Epigenetics & Chromatin. 8(1). 48–48. 21 indexed citations
19.
Boija, Ann & Mattias Mannervik. (2015). A time of change: Dynamics of chromatin and transcriptional regulation during nuclear programming in early Drosophila development. Molecular Reproduction and Development. 82(10). 735–746. 6 indexed citations
20.
Holmqvist, Per-Henrik, et al.. (2012). Preferential Genome Targeting of the CBP Co-Activator by Rel and Smad Proteins in Early Drosophila melanogaster Embryos. PLoS Genetics. 8(6). e1002769–e1002769. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026